SB 676-FN (2020): relative to the controlled drug prescription health and safety program.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 676-FN (2020): relative to the controlled drug prescription health and safety program.” Granite Record, https://graniterecord.org/bill/2020/sb676. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 676-FN (2020): relative to the controlled drug prescription health and safety program. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/sb676
Chicago
Granite Record. “SB 676-FN (2020): relative to the controlled drug prescription health and safety program.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/sb676.
BibTeX
@misc{bill-2020-sb676, title = {SB 676-FN (2020): relative to the controlled drug prescription health and safety program.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/sb676}, note = {Accessed 24 Oct. 2026} }

SB 676-FN (2020)

relative to the controlled drug prescription health and safety program.

  • Status: Died on the table
  • Term: 2019-2020
  • Senate committee: Health and Human Services
  • Subject: Public and Mental Health

The Story

It was introduced on January 8, 2020 and referred to the Senate Health and Human Services committee. The committee held a public hearing on February 18, 2020. The committee recommended that the Senate pass it with changes (amendment 2020-0776s). The committee's amendment (2020-0776s) was adopted on a voice vote on March 5, 2020, changing the text of the bill. A floor amendment (2020-0987s), offered by Sen. Sherman, was adopted on a voice vote on March 5, 2020, changing the text of the bill. On March 5, 2020 the Senate voted to pass it with changes on a voice vote, then referred it on to the Senate Finance committee. The committee recommended that the Senate study it after the session ends. On June 16, 2020 the Senate adopted “Placed on Laid on Table Consent List and Laid on Table” on a voice vote. The bill died on the table under Senate Rule 3-23 at adjournment on September 16, 2020, having been set aside and never taken back up.

Sponsors

Hearings and Sessions

  • February 18, 2020, 3:30 PM: hearing, Senate Health and Human Services, LOB 101

Votes

  • March 5, 2020, Senate: Ought to Pass with Amendment s 2020-0776s, and 2020-0987s — voice vote, passed
  • June 16, 2020, Senate: Placed on Laid on Table Consent List and Laid on Table — voice vote, passed

The Docket

  • January 8, 2020: Introduced 01/08/2020 and Referred to Health and Human Services
  • February 18, 2020: Hearing: 02/18/2020, Room 101, LOB, 03:30 pm
  • March 5, 2020: Committee Report: Ought to Pass with Amendment #2020-0776s , 03/05/2020
  • March 5, 2020: Committee Amendment #2020-0776s , AA, VV; 03/05/2020
  • March 5, 2020: Sen. Sherman Floor Amendment #2020-0987s , AA, VV; 03/05/2020
  • March 5, 2020: Ought to Pass with Amendment s 2020-0776s, and 2020-0987s, MA, VV; Refer to Finance Rule 4-5; 03/05/2020
  • March 11, 2020: Committee Report: Referred to Interim Study
  • June 16, 2020: Placed on Laid on Table Consent List and Laid on Table, MA, VV; 06/16/2020
  • September 16, 2020: Inexpedient to Legislate, Senate Rule 3-23, Adjournment 09/16/2020

Laws It Would Change

Related Bills

  • SB 45 (2021): relative to the controlled drug prescription health and safety program.

From the General Court